Health Catalyst and MedRhythms aim to develop a digital therapeutic incorporating AI-generated music and sensor data to help stroke survivors walk.
After four years under the radar, Medtronic made its relationship with endoscope maker Karl Storz official "to enable upcoming regulatory filings.”
Genome Medical has raised $23 million to help scale up its patient counseling services for healthcare systems and individuals across the U.S.
The FDA has approved the first medical device to help reduce abdominal pain in adolescents with IBS through the use of nerve stimulation.
Thomas Schinecker, global business head of the division’s burgeoning centralized and point-of-care solutions, will take over as CEO Aug. 1.
Medtronic teamed with Tidepool for an interoperable version of its MiniMed pump and will help Tidepool secure the FDA’s OK for its app in return.
Insulet presented new data evaluating the use of its tubeless, closed-loop Omnipod insulin management system in young children with Type 1 diabetes.
Abbott found that the system was able to significantly reduce hemoglobin A1c levels among patients who take multiple insulin injections per day.
Early clinical data from Fractyl showed its outpatient procedure could help eliminate several months’ worth of insulin injections.
Former Juno Therapeutics helmsman Hans Bishop will pick up Grail’s quest to develop a simple pan-cancer liquid biopsy.